Yatharth Hospital & Trauma Care Services Ltd
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]
- Market Cap ₹ 10,242 Cr.
- Current Price ₹ 1,063
- High / Low ₹ 1,184 / 538
- Stock P/E 53.8
- Book Value ₹ 195
- Dividend Yield 0.05 %
- ROCE 12.9 %
- ROE 10.2 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 57.1% CAGR over last 5 years
- Company's working capital requirements have reduced from 101 days to 80.1 days
Cons
- Company has a low return on equity of 12.1% over last 3 years.
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -10.5%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of Nifty Microcap 250 Nifty Total Market BSE Hospitals Nifty Smallcap 500 BSE Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 71 | 78 | 91 | 136 | 215 | 375 | 478 | 635 | 886 | 1,207 | 1,486 | |
| Sales growth | +10% | +17% | +49% | +58% | +74% | +27% | +33% | +40% | +36% | +50% | |
| 53 | 60 | 71 | 98 | 147 | 263 | 343 | 453 | 655 | 902 | 1,138 | |
| Operating Profit | 18 | 18 | 20 | 38 | 68 | 112 | 135 | 182 | 230 | 305 | 348 |
| OPM % | 25% | 24% | 22% | 28% | 32% | 30% | 28% | 29% | 26% | 25% | 23% |
| 0 | 0 | 0 | 0 | 1 | 2 | 3 | 16 | 11 | 25 | 24 | |
| Interest | 6 | 5 | 7 | 20 | 20 | 23 | 23 | 11 | 12 | 19 | 21 |
| Depreciation | 7 | 6 | 8 | 21 | 21 | 28 | 28 | 29 | 57 | 88 | 115 |
| Profit before tax | 5 | 8 | 5 | -2 | 28 | 63 | 88 | 157 | 172 | 224 | 236 |
| Tax % | 41% | 23% | 21% | -18% | 30% | 30% | 25% | 27% | 24% | 24% | |
| 3 | 6 | 4 | -2 | 20 | 44 | 66 | 114 | 131 | 170 | 182 | |
| EPS in Rs | 0.55 | 0.94 | 0.61 | -0.20 | 2.77 | 6.74 | 10.04 | 13.33 | 13.55 | 18.20 | 19.77 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 36% |
| TTM: | 50% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 57% |
| 3 Years: | 38% |
| TTM: | 25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 40% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 14% |
| 3 Years: | 12% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 16 | 16 | 16 | 16 | 66 | 66 | 86 | 96 | 96 | 96 |
| Reserves | 29 | 41 | 39 | 38 | 56 | 51 | 117 | 788 | 1,509 | 1,684 | 1,779 |
| 85 | 125 | 175 | 194 | 193 | 264 | 267 | 85 | 12 | 264 | 468 | |
| 10 | 11 | 26 | 39 | 43 | 45 | 36 | 60 | 114 | 218 | 247 | |
| Total Liabilities | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,731 | 2,262 | 2,591 |
| 54 | 53 | 164 | 189 | 251 | 303 | 299 | 442 | 605 | 1,250 | 1,322 | |
| CWIP | 64 | 110 | 65 | 62 | 0 | 0 | 0 | 0 | 222 | 102 | 242 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 2 | 2 |
| 20 | 30 | 27 | 36 | 58 | 123 | 187 | 577 | 829 | 909 | 1,025 | |
| Total Assets | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,731 | 2,262 | 2,591 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 25 | 17 | 17 | 39 | 44 | 60 | 64 | -3 | 131 | 205 | |
| -50 | -51 | -78 | -43 | -21 | -52 | -20 | -226 | -388 | -598 | |
| 26 | 43 | 47 | 5 | -19 | -1 | -18 | 304 | 509 | 254 | |
| Net Cash Flow | 1 | 9 | -13 | 1 | 3 | 7 | 26 | 75 | 253 | -140 |
| Free Cash Flow | 24 | 16 | -60 | -4 | 24 | 21 | 44 | -96 | -171 | -112 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 148% | 103% | 99% | 109% | 67% | 65% | 75% | 22% | 68% | 94% |
Ratios
Consolidated / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 44 | 48 | 45 | 62 | 83 | 82 | 131 | 124 | 113 |
| Inventory Days | 47 | 42 | 88 | 72 | 43 | 32 | ||||
| Days Payable | 127 | 106 | 490 | 347 | 60 | 171 | ||||
| Cash Conversion Cycle | -22 | -20 | -354 | -229 | 62 | 83 | 82 | 131 | 107 | -26 |
| Working Capital Days | 44 | 29 | -75 | -89 | -18 | 0 | 29 | 118 | 106 | 80 |
| ROCE % | 8% | 6% | 7% | 18% | 26% | 27% | 24% | 14% | 13% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| ALOS (Average Length of Stay) days |
|
|||||
| ARPOB (Average Revenue Per Occupied Bed) Rs |
||||||
| Bed Occupancy Rate % |
||||||
| IPD Volume '000 (thousands) |
||||||
| Number of Operational Hospitals count |
||||||
| OPD Volume '000 (thousands) |
||||||
| Operational Bed Capacity beds |
||||||
| Operational Census Beds beds |
||||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Announcement Under Regulation 30 (LODR)- CCI Approval
- CCI approved Yatharth Hospital's ₹31,500 million preferential issue to Rasmalai Limited for 24.87% stake.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- CARE report for Q2FY27 shows nil deviation, ₹48.45 crore unutilised, extension till March 31, 2027.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Audio recording of Q2FY27 earnings call held on November 4, 2026 is now available online.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- We hereby submit Newspaper Publication of Unaudited Financial Results - Q2FY27.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
Concalls
-
Nov 2026Transcript PPT REC
-
Aug 2026Transcript PPT REC
-
Aug 2026PPT
-
Jun 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript
-
Nov 2023Transcript PPT
-
Nov 2023PPT
-
Aug 2023Transcript PPT
Hospital Portfolio:[1]
Yatharth operates a network of multi-specialty and super-specialty hospitals primarily in North India, focusing on tertiary care, trauma services, and advanced treatments.
The company operates 9 hospitals with
total bed capacity exceeding 2,800 beds
and maintains 12 Centres of Excellence
across specialties. The 80% of beds are
located in metro cities, providing access
to high-demand healthcare markets.[2]